{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/147253611"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "The Patients' Access to Treatment Act (PATA) would significantly limit how much consumers pay for ???specialty tier??? ??? or Tier 4 ??? drugs, which include biologics that treat autoimmune forms of arthritis, as well as drugs for multiple sclerosis, cancer and other serious conditions." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "arthritistoday.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/424431652"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/147253611"] } } }
